The C-Terminus of Panusin, a Lobster β-Defensin, Is Crucial for Optimal Antimicrobial Activity and Serum Stability
暂无分享,去创建一个
D. Andreu | Javier Valle | M. Torrent | Corina Ciobanasu | V. Montero-Alejo | A. Petre | Roberto Bello-Madruga | M. J. N. U. nez
[1] D. Pan,et al. Advances in the stability challenges of bioactive peptides and improvement strategies , 2022, Current research in food science.
[2] Daryl R. Williams,et al. Strategies for Improving Peptide Stability and Delivery , 2022, Pharmaceuticals.
[3] P. Grieco,et al. Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs , 2022, International journal of molecular sciences.
[4] S. Ovchinnikov,et al. ColabFold: making protein folding accessible to all , 2022, Nature Methods.
[5] David Andreu,et al. The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for Harmonization. , 2020, Angewandte Chemie.
[6] M. Mahlapuu,et al. Antimicrobial peptides as therapeutic agents: opportunities and challenges , 2020, Critical reviews in biotechnology.
[7] P. Harvey,et al. Synthesis, structure, and activity of the antifungal plant defensin PvD1. , 2020, Journal of medicinal chemistry.
[8] Ines Greco,et al. Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides , 2020, Scientific Reports.
[9] G. Bonacucina,et al. Surfactant Self-Assembling and Critical Micelle Concentration: One Approach Fits All? , 2020, Langmuir : the ACS journal of surfaces and colloids.
[10] S. Gronow,et al. Influence of disulfide bonds in human beta defensin-3 on its strain specific activity against Gram-negative bacteria. , 2020, Biochimica et biophysica acta. Biomembranes.
[11] M. Jiménez,et al. Effect of phosphorylation in the structural behavior of peptides derived from the intrinsically disordered C-terminal domain of Histone H1.0. , 2020, Chemistry.
[12] G. Bou,et al. Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases , 2020, Antibiotics.
[13] D. Andreu,et al. Structural determinants conferring unusual long life in human serum to rattlesnake‐derived antimicrobial peptide Ctn[15‐34] , 2019, Journal of peptide science : an official publication of the European Peptide Society.
[14] M. Schaller,et al. Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide , 2019, Scientific Reports.
[15] M. Amerikova,et al. Antimicrobial activity, mechanism of action, and methods for stabilisation of defensins as new therapeutic agents , 2019, Biotechnology & Biotechnological Equipment.
[16] Hong Yang,et al. Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability. , 2018, Current drug metabolism.
[17] Muhammad Sohail Zafar,et al. Human Oral Defensins Antimicrobial Peptides: A Future Promising Antimicrobial Drug. , 2018, Current pharmaceutical design.
[18] O. Yamasaki,et al. Two arginine residues in the COOH‐terminal of human β‐defensin‐3 constitute an essential motif for antimicrobial activity and IL‐6 production , 2017, Experimental dermatology.
[19] G. Morelli,et al. Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics , 2017, Molecules.
[20] R. Hoffmann,et al. Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum , 2017, PloS one.
[21] J. Tytgat,et al. Panusin represents a new family of &bgr;‐defensin‐like peptides in invertebrates , 2017, Developmental and comparative immunology.
[22] Shicui Zhang,et al. Identification of a novel antimicrobial peptide from amphioxus Branchiostoma japonicum by in silico and functional analyses , 2015, Scientific Reports.
[23] M. Mura,et al. The role of C-terminal amidation in the membrane interactions of the anionic antimicrobial peptide, maximin H5. , 2015, Biochimica et biophysica acta.
[24] R. Kar,et al. Membrane disruptive antimicrobial activities of human β-defensin-3 analogs. , 2015, European journal of medicinal chemistry.
[25] Woonghee Lee,et al. NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy , 2014, Bioinform..
[26] A. Bax,et al. Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks , 2013, Journal of Biomolecular NMR.
[27] D. Craik,et al. The α-defensin salt-bridge induces backbone stability to facilitate folding and confer proteolytic resistance , 2012, Amino Acids.
[28] Yang Shen,et al. Prediction of Xaa-Pro peptide bond conformation from sequence and chemical shifts , 2010, Journal of biomolecular NMR.
[29] A. Schmidtchen,et al. Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37 , 2008, Antimicrobial Agents and Chemotherapy.
[30] H. G. Boman,et al. Antibacterial peptides: basic facts and emerging concepts , 2003, Journal of internal medicine.
[31] Dirk Labudde,et al. A software tool for the prediction of Xaa-Pro peptide bond conformations in proteins based on 13C chemical shift statistics , 2002, Journal of biomolecular NMR.
[32] K. Rajarathnam,et al. 13C NMR chemical shifts can predict disulfide bond formation , 2000, Journal of biomolecular NMR.
[33] M. Billeter,et al. MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.
[34] K Wüthrich,et al. Polypeptide secondary structure determination by nuclear magnetic resonance observation of short proton-proton distances. , 1984, Journal of molecular biology.
[35] Yang Shen,et al. Protein structural information derived from NMR chemical shift with the neural network program TALOS-N. , 2015, Methods in molecular biology.
[36] N. Greenfield. Using circular dichroism spectra to estimate protein secondary structure , 2007, Nature Protocols.
[37] M. T. Miranda,et al. Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. , 2006, Biopolymers.
[38] P. Güntert. Automated NMR structure calculation with CYANA. , 2004, Methods in molecular biology.
[39] Jacek Lubkowski,et al. Antimicrobial characterization of human beta-defensin 3 derivatives. , 2003, Antimicrobial agents and chemotherapy.
[40] R D Appel,et al. Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.